Expired blood products are primarily associated with which of the following risks?

Expired blood products primarily pose a risk related to their decreased effectiveness in treatment. When blood products expire, they may begin to lose their potency and essential therapeutic qualities. This can lead to a compromised ability to deliver critical components like red blood cells, platelets, or clotting factors that are necessary for effective patient care. For example, the transfusion of expired blood may result in reduced efficacy in addressing the patient's condition, such as anemia or bleeding disorders, ultimately endangering the patient’s health.

This deterioration in effectiveness underlines the importance of strict adherence to transfusion guidelines that emphasize the use of only those products that are within their expiration date to ensure patient safety. In contrast, increased storage costs, higher rates of blood donation, and improved recovery times do not correlate with the risks posed by expired blood products. Rather, those options are focused on aspects unrelated to the immediate clinical implications of using outdated blood.